key: cord-0899342-9k70s28s
authors: Villaverde, S.; Domínguez-Rodríguez, S.; Sabrido, G.; Pérez-Jorge, C.; Plata, M.; Romero, M.P.; Grasa, C.; Jiménez, A.B.; Heras, E.; Broncano, A.; Núñez, M.; Illán, M.; Merino, P.; Soto, B.; Molina-Arana, D.; Bermejo, A.; Mendoza, P.; Gijón, M.; Pérez-Moneo, B.; Moraleda, C.; Tagarro, A.
title: Diagnostic Accuracy of the Panbio SARS-CoV-2 Antigen Rapid Test Compared with Rt-Pcr Testing of Nasopharyngeal Samples in the Pediatric Population
date: 2021-01-21
journal: J Pediatr
DOI: 10.1016/j.jpeds.2021.01.027
sha: 62c445931e25f49f10e5e81e72e57c681608858f
doc_id: 899342
cord_uid: 9k70s28s

We conducted a multicenter clinical validity study of the Panbio COVID-19 Antigen Rapid Test of nasopharyngeal samples in pediatric patients with COVID-19 compatible symptoms of ≤5 days of evolution. Our study showed limited accuracy in nasopharyngeal antigen testing: overall sensitivity was 45.4%, and 99.8% of specificity, positive-predictive value was 92.5%.

. Nevertheless, there is a lack of evidence about the accuracy of rapid antigen tests in the pediatric population.

Our objective was to determine the sensitivity, specificity, positive-and negative-predictive values and concordance of the Panbio COVID-19 Ag Rapid Test by Abbott in NPS samples in symptomatic pediatric population compared with RT-PCR testing.

This was a descriptive, retrospective, multicenter clinical validity study nested in a prospective, observational, multicenter cohort study (Epidemiological Study of COVID-19 in Children of the Spanish Society of Pediatric; EPICO-AEP). We included 1620 pediatric patients aged 0 to 16 years J o u r n a l P r e -p r o o f 4 with symptoms compatible with SARS-CoV-2 infection of ≤5 days of evolution attended in the Emergency Departments of the seven centers involved. Asymptomatic patients with close contact with COVID-19 patients were excluded. The study was conducted in September and October 2020.

Verbal consent for paired testing was obtained. The study was approved by the Fundación de Investigacion Biomédica del Hospital 12 de Octubre Ethics Committee (code 20/101).

Two NPS were obtained concurrently from each patient by trained nurses. One was employed to perform the rapid antigenic test and the other to carry out the RT-PCR. We applied on-site the 

Sample size for a non-inferiority study was calculated considering 80% power, for a 5% prevalence and a 90% sensitivity, using RT-PCR as the gold standard reference. A minimum sample of 1200 participants was calculated. A confusion matrix was displayed, and accuracy, sensitivity, specificity, and predictive positive and negative values were calculated. Associated 95% confidence interval was estimated using Clopper-Pearson confidence intervals. Non-inferiority of sensitivity and specificity between diagnostic tests was assessed using the McNemar test. The agreement J o u r n a l P r e -p r o o f between the two methods was calculated using Cohen kappa index. Statistical analyses were performed using R Software 5 . There is evidence of a systematic difference between results from the two diagnostic tests (P value=1.47 ·10 -08 ). A moderate agreement (k=0.6) was found between the two methods. implications for the treatment received by the patient. However, RT-PCR positivity can persist for some weeks after a SARS-CoV-2 infection 6 . We cannot exclude the possibility that discordant results are due to the persistence of a previous SARS-CoV-2 infection in children with symptoms due to another pathogen. In these cases, the antigen test could better reflect the contagiousness of patient than would RT-PCT, but the concordance between contagiousness and RT-PCR or antigen positivity is not clearly known.

The predictive values were good, beyond 95%. The predictive value of a test depends on the pretest probability. In this study, the prevalence of SARS-CoV-2 infection was almost 5%. This prevalence was the current real situation among children attended in Emergency Departments in several Spanish cities, where the test is being used as a point-of-care technique. To assess the implication of these results in different prevalence settings, we calculated likelihood ratios. The high PLR suggests that the test is good when the result is positive, and the low NLR indicates that the test has only limited value when the result is negative. In this scenario, with a prevalence of 5%, a positive result will identify the infection in 92.5% (95%CI, 79.5-97.5%) of symptomatic cases.

A negative result we will be wrong in 2.8% (95%CI, 2.3-3.4%), making it necessary to perform 35 tests to misdiagnose a patient. An increase in prevalence would lead to an increase in the chances of having the infection with a negative test result.

The low sensitivity and negative likelihood ratio of the antigen test may question its value as a diagnostic tool. Nevertheless, in a pandemic situation, a cheap, rapid and widely distributed test with a good positive likelihood ratio may be worthy as a first screening test 7 . Still, pediatricians should be aware of the actual accuracy and establish sequential strategies of diagnosis if needed.

Previous studies in adults have evaluated the validity of the Panbio TM COVID-19 Ag Rapid Test compared with RT-PCR testing in symptomatic adults with fewer than 7 days of symptoms. The J o u r n a l P r e -p r o o f authors found a higher antigen test sensitivity in 327 adults (82.6%) compared with sensitivity in 85 pediatric patients (62.5%) 3, 4 . The difference between both populations could be related to differences in SARS-CoV-2 viral load in the upper respiratory tract between children and adults.

Another similar study showed that the sensitivity of other Ag Rapid Test (Bioeasy 2019-Novel Coronavirus Fluorescence Antigen Rapid Test Kit, Shenzhen, China) was significantly higher in samples with high viral loads 8 . However, previous studies found no age-related differences in SARS-CoV-2 nasopharyngeal viral load 9.10 . This study has several limitations. Sample size calculation was done with an assumption of 90% sensitivity based on the manufacturer's information, so the final statistical power was lower than expected. Still, the sample size is large. We did not record the specific symptoms, sampling day after onset, coinfections, or the cycle-threshold (CT) values of RT-PCR, so we do not know if a high CT value could be related to a lower sensitivity of the comparative antigen test. Equipment for RT-PCR test was not uniform, and samples with CT close to the threshold may represent equivocal results. Viral culture was not performed, so the relationship between contagiousness, RT-PCR and antigen is unclear. Ongoing research of the study team will include some of this information. In the current pandemic situation, our data should be considered by clinicians and policymakers in order to understand the limited accuracy of the Panbio COVID-19 Ag Rapid Test as performed on NPS samples of children with symptoms consistent with COVID-19 of less than 5 days of duration.

Instituto de Investigación Sanitaria Hospital 12 de

Fundación para la Investigación Biomédica Hospital 12 de Octubre

Infectious and Tropical Diseases

REFERENCES 1. National Center for Immunization and Respiratory Diseases (NCIRD) D of VD. Overview of Testing for SARS-CoV-2 (COVID-19)

National Center for Immunization and Respiratory Diseases (NCIRD) D of VD. Information for Laboratories about Coronavirus (COVID-19)

Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms

Field evaluation of a rapid antigen test (Panbio COVID-19 Ag Rapid Test Device) for the diagnosis of COVID-19 in primary healthcare centers

Building Bivariate tables: The compareGroups package for R

Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation?

Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance

Evaluation of a novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples

Regularization and variable selection via the elastic net

Rojo: MD, PhD, Pediatric Department, Hospital 12 de Octubre

José Luis Vázquez: MD, Microbiology Department, Hospital Ramón y Cajal

Sara Gutiérrez: MD, Pediatric Department